The HSI inched up 99 points or 0.4% to close at 23,381. The HSCEI lifted 32 points or 0.4% to close at 8,469. The HSTECH added 24 points or 0.5% to close at 5,182. Total market turnover for the day amounted to $203.268 billion.

MEITUAN-W (03690.HK)  +6.500 (+4.947%)    Short selling $1.22B; Ratio 20.856%   reported a 46.2% YoY hike in 1Q non-IFRS adjusted profit, beating expectations, but warned of a YoY plunge in core local commerce operating profit for 2Q. MEITUAN-W once cratered 5.5%, and closed up 2.1% at $132.1. JD-SW (09618.HK)  +1.200 (+0.949%)    Short selling $88.72M; Ratio 10.626%   dropped 1% to $128.3, while BABA-W (09988.HK)  +0.900 (+0.778%)    Short selling $426.93M; Ratio 11.068%   picked up 0.9% to $118. The meeting of the State Council's Anti-Monopoly and Anti-Unfair Competition Committee Expert Advisory Group was recently held in Beijing to address 'involutionary' competition.

Pharma elevated. GENSCRIPT BIO (01548.HK)  +0.020 (+0.158%)    Short selling $12.60M; Ratio 8.006%   , INNOVENT BIO (01801.HK)  -0.200 (-0.332%)    Short selling $43.60M; Ratio 9.407%   , CSPC PHARMA (01093.HK)  +0.200 (+2.933%)    Short selling $141.60M; Ratio 19.231%   , LUYE PHARMA (02186.HK)  +0.070 (+3.070%)    Short selling $18.56M; Ratio 10.919%   and PHARMARON (03759.HK)  +0.620 (+4.379%)    Short selling $1.97M; Ratio 1.558%   advanced 5.3-6.5%, while SINO BIOPHARM (01177.HK)  +0.080 (+1.909%)    Short selling $33.95M; Ratio 20.948%   and HANSOH PHARMA (03692.HK)  0.000 (0.000%)    Short selling $39.72M; Ratio 28.388%   leaped 4.7 and 3.7%. Listed IPO HENGRUI PHARMA (01276.HK)  -0.950 (-1.652%)   climbed 2.2%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-29 12:25.)